(Q46496638)

22 December 2017

title

Intravenous administration of CP-4055 (ELACYT) in patients with solid tumours. A Phase I study (English)

1 reference

22 December 2017

author name string

Svein Dueland

1

1 reference

22 December 2017

Steinar Aamdal

2

1 reference

22 December 2017

Michael J Lind

3

1 reference

22 December 2017

Hilary Thomas

4

1 reference

22 December 2017

Marit Liland Sandvold

5

1 reference

22 December 2017

Jean-Michel Gaullier

6

1 reference

22 December 2017

Wenche Rasch

7

1 reference

22 December 2017

publication date

1 January 2009

1 reference

22 December 2017

published in

Acta Oncologica

1 reference

22 December 2017

volume

48

1 reference

22 December 2017

issue

1

1 reference

22 December 2017

page(s)

137-145

1 reference

22 December 2017

cites work

Melanoma chemoprevention

1 reference

https://api.crossref.org/works/10.1080%2F02841860802183620

Chemotherapy for metastatic melanoma: time for a change?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802183620

Novel treatment strategies for malignant melanoma: a new beginning?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802183620

Patterns and progress in ovarian cancer over 14 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802183620

Ovarian cancer: a focus on management of recurrent disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802183620

Lung cancer in never smokers: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802183620

1-Beta-arabinofuranosylcytosine in therapy of leukemia: preclinical and clinical overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802183620

Long intracellular retention of 4'-thio-arabinofuranosylcytosine 5'-triphosphate as a critical factor for the anti-solid tumor activity of 4'-thio-arabinofuranosylcytosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802183620

Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802183620

Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinosylcytosine (ara-C) in leukemia and solid tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802183620

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802183620

The toxicity of cytarabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802183620

High-dose cytosine arabinoside: pharmacological and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860802183620

10.1080/02841860802183620

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017